Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Reminder for tomorrow

$Corvus Pharmaceuticals (CRVS.US)$ Corvus Pharmaceuticals to Announce Interim Data From Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on December 18, 2024
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
+0
Translate
Report
1376 Views
Comment
Sign in to post a comment